The efficacy of targeted therapies against mutationally activated kinases is typically limited by the engagement of growth-promoting cues that compensate for inhibition of the targeted kinase. Initial studies have highlighted the contribution of genomic alterations, functional characteristics, and signaling feedback loops-all intrinsic to cancer cells-in sustaining such substitute activities. New evidence now indicates that the relative expression of growth factor ligands produced by the tumor microenvironment can relay redundant survival pathways, which may broadly impair responsiveness to kinase inhibitors.

Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: Six degrees of separation

TRUSOLINO, Livio;BERTOTTI, Andrea
2012-01-01

Abstract

The efficacy of targeted therapies against mutationally activated kinases is typically limited by the engagement of growth-promoting cues that compensate for inhibition of the targeted kinase. Initial studies have highlighted the contribution of genomic alterations, functional characteristics, and signaling feedback loops-all intrinsic to cancer cells-in sustaining such substitute activities. New evidence now indicates that the relative expression of growth factor ligands produced by the tumor microenvironment can relay redundant survival pathways, which may broadly impair responsiveness to kinase inhibitors.
2012
2
10
876
880
http://cancerdiscovery.aacrjournals.org/content/2/10/876.long
BREAST-CANCER; INHIBITORS; EGFR; HETEROGENEITY; FEEDBACK
Trusolino L; Bertotti A
File in questo prodotto:
File Dimensione Formato  
Trusolino and Bertotti Cancer Discovery 2012.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/122160
Citazioni
  • ???jsp.display-item.citation.pmc??? 39
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 71
social impact